1
CORRESPONDENCE Currently, the cost for materials to synthesize GHB IS approximately $50/1 00 g, and the cost for GBL is $156/L. Since our reports, we have received many requests from physicians on proper methods for GHB toxicologic testing GHB is readily detected uSing standard gas chromatography- mass spectrometry(GC-MS) methods. GHB can be routinely detected and levels quanti- fied In samples of serum, plasma, blood, and urine provided specific request is made to the toxicology laboratory so that search forthe mass spectrometry pattern is performed. If GC-MS testing is unavailable locally, specI- mens can be frozen and tested elsewhere at a later date Testing is available from several national forensic and toxicology laboratories, and costs approximately $100 per specimen (National Medical Services, Willow Grove, PA, 800-522-6671). For cases of sexual assault, Hoffman-La Roche provides a combined GC- MS assay free of charge for flunitrazepam (Rohypnoll. GHB, and alcohol (Hoffman-La Roche Sexual Assault Hotline; 800-608-6540). Since our report. an additional GHB- related death has been reported, bnnging the tota I known deaths to 10. 2 Because of the widespread use and availability of GBL In industry, It is unlikelythatthis substance will soon be regulated. Ease of GHB synthe- sis, as well as substitution of GBL for GHB abuse, may lead to epidemics of abuse. To readers who may participate in illiCit use of these substances, we reiterate the inherent danger of noncontrolled use, due to direct effects of GHB and GBL. to further toxicity when these are combined With alcohol or other drugs of abuse, and to toxic effects of by-products and imp unties associated With home synthesis. To phYSicians, we reiterate the need for suspicion of GHB (or related) tOXICity in cases of unknown ingestIOn with altered mentation. Suspected cases should be treated With Vigilance toward respi ratory failure, as detailed previously, with appro- pnate toxicologiC testing and law enforce- ment notification. JamesLI, MD DIVision of Emergency Medlcme Mount Auburn Hospital Harvard Medical School Cambndge, MA 47/8/97564 1 Fowkes S GHB Report to the Californw Legrslature Menlo Park. CA Cogmtlve Enhancement Research InstItute. 1998 2 KGTV News. San DIego Woman launches Intenlct em- sade agaInst popular Illegal party drug [broadealtJ June 29,1998 In reply: We agree with the need to be aware of GBL and that mass spectrometry cannot differen- tiate GBL ingestion from GHB ingestion In unne or serum samples. However, It is possi- ble to differentiate GHB and GBL in urine samples, by using gas chromatography and flame IOnization.' We believe that GBL Ingestion was not widespread at the time of our study, but has increased since then GBL has greater bioavaliabliity than GHB when given orally In the same dose GBL is rapidly converted in the body by penpheral lactonases to GHB within minutes. Anotherchemlcal precursorto GHB IS 1,4- butanediol (1 ,4-BOl. sometimes called "pine needle oil "21t is converted by alcohol dehy- drogenase to y-hydroxybutyraldehyde, then by aldehyde dehydrogenase to GHB. Whereas GHB is acontrolled drug in several states, GBL and 1 ,4-BO are not yet classified as such, and both drugs are readily available through chemical supply catalogs Rachel L Chin, MD Jo Ellen Dyer, PharmD Karl A Sporer, MD San Francisco General Hospital 1001 Potrero Avenue, Room lE21 San Francisco, CA 94110 47/8/97565 1 LoVecchIO F, Curry SC, Bagnasco T Butyrolactone- Induced central nervous system depreSSIOn after IngestIOn of RenewTnent. a "dIetary supplement" N Engl J Med 1998,339 847-848 2 Dyer jE. Galbo Mj, Andrews KM I,4-Butanedwl. "pIne needle 011," overdose mlmlCS tOXIC profIle of GHB [abstractJ elm TOXlCOl 1997.35554 More on the Ottawa Knee Rules To the Editor: Clinical decision rules hold the promise to reduce health care costs while maintaining an optimal level of patient care The emer- gency medicine community and physicians from other specialties have recognized the importance ofthe contributions of Dr Ian Stiell and hiS colleagues toward the develop- ment of such rules to reduce extremity radlo- graphy.1.2 Atthe same time, It is Important for other centers to independently validate the deci- sion rules that have been developed In Ottawa The report by Seaberg et al 3 raises senous concerns about the sensitivity of the Ottawa knee rules If any decision rule for extremity radiography is to be widely appli- cable, it must be broadly reproducible with 100% sensitiVity. Unfortunately, Seaberg's group found that the Ottawa knee rule was only 97% senSitive forthe detection of fractures We also recently reported aprospective validation trial ofthe Ottawa knee rules In 351 patients. 4 Like Seaberg et ai, we found that that the rule developed by Dr Stiell missed several fractures 4 The overall sensitivity of the Ottawa rule in our study was only 84.6%. The reasons that the Ottawa rules were less sensitive In these Independenttnals are unclear One particular concern that we have had the opportunity to diSCUSS with Dr Stiell is thatthe "Intensive" instruction thatthe physicians received In Ottawa versus the other centers may not have been uniform. It is essen- tial to future validation studies that Dr Stiell outline in detail his methods fortraining phYSI- cians In the use ofthe Ottawa knee rules The work of the group In Pittsburgh suggests that clinicians should not use any of the cur- rent clinical deciSIOn rules for knee radiogra- phy as a rigid standard that replaces clinical judgment altogether. The Pittsburgh rule must be Independently validated and refined Atthe same time, further validation tnals ofthe Ottawa knee rules that ensure conformity to the phYSician instruction methods developed by Dr Stlell are warranted Peter B Richman, MD Department of Emergency Medicine Morristown Memorial Hospital Morristown, NJ 47/8/97566 1 Stlell IG, Greenberg GH, McKmght RD. et al DeCISIOn mles for the use of radIOgraphy In acute ankle InJunes RefInement and prospectlve valIdatIOn JAMA 1993.269 1I27-1I32 2 StlelllG. Greenberg GH, Wells GA, et al ProspectIve valtdatIOn of a denswn mle for the u," of radIOgraphy In acute kna InJunel JAMA 1996,275 611-6/5 3 Seaberg DC, realy DM Lukens T, et al MultIcenter companson of two clInIcal dwsIOn mles tor the usc of radIOgraphy In acute. hIgh-nsk knee InJun" Ann Emng Med 1998,32 8- 13 4 Richman PRo McCuskey CF, Nashed AN. et al Performance of two clInIcal deCISIOn mles for knee radlOg- raphy J Emcrg Mcd 1997,15 459-463 476 ANNALS OF EMERGENCY MEDICINE 334 APRIL 1999

In Reply:

Embed Size (px)

Citation preview

CORRESPONDENCE

Currently, the cost for materials to synthesizeGHB IS approximately $50/1 00 g, and the costfor GBL is $156/L.

Since our reports, we have received manyrequests from physicians on proper methodsfor GHB toxicologic testing GHB is readilydetected uSing standard gas chromatography­mass spectrometry(GC-MS) methods. GHBcan be routinely detected and levels quanti­fied In samples of serum, plasma, blood, andurine provided specific request is made tothe toxicology laboratory so that search forthemass spectrometry pattern is performed. IfGC-MS testing is unavailable locally, specI­mens can be frozen and tested elsewhere at alater date Testing is available from severalnational forensic and toxicology laboratories,and costs approximately $100 per specimen(National Medical Services, Willow Grove,PA, 800-522-6671). For cases of sexual assault,Hoffman-La Roche provides acombined GC­MS assay free of charge for flunitrazepam(Rohypnoll. GHB, and alcohol (Hoffman-LaRoche Sexual Assault Hotline; 800-608-6540).

Since our report. an additional GHB­related death has been reported, bnnging thetota Iknown deaths to 10.2Because of thewidespread use and availability of GBL Inindustry, It is unlikelythatthis substancewill soon be regulated. Ease of GHB synthe­sis, as well as substitution of GBL for GHBabuse, may lead to epidemics of abuse. Toreaders who may participate in illiCit use ofthese substances, we reiterate the inherentdanger of noncontrolled use, due to directeffects of GHB and GBL. to further toxicitywhen these are combined With alcohol orother drugs of abuse, and to toxic effects ofby-products and impunties associated Withhome synthesis. To phYSicians, we reiteratethe need for suspicion of GHB (or related)tOXICity in cases of unknown ingestIOn withaltered mentation. Suspected cases shouldbe treated With Vigilance toward respi ratoryfailure, as detailed previously, with appro­pnate toxicologiC testing and law enforce­ment notification.

JamesLI, MDDIVision of Emergency MedlcmeMount Auburn HospitalHarvard Medical SchoolCambndge, MA47/8/97564

1 Fowkes S GHB Report to the Californw LegrslatureMenlo Park. CA Cogmtlve Enhancement ResearchInstItute. 1998

2 KGTV News. San DIego Woman launches Intenlct em­sade agaInst popular Illegal party drug [broadealtJ June29,1998

In reply:

We agree with the need to be aware of GBLand that mass spectrometry cannot differen­tiate GBL ingestion from GHB ingestion In

unne or serum samples. However, It is possi­ble to differentiate GHB and GBL in urinesamples, by using gas chromatography andflame IOnization.'

We believe that GBL Ingestion was notwidespread at the time of our study, but hasincreased since then

GBL has greater bioavaliabliity than GHBwhen given orally In the same dose GBL israpidly converted in the body by penpherallactonases to GHB within minutes.

Anotherchemlcal precursorto GHB IS 1,4­butanediol (1 ,4-BOl. sometimes called "pineneedle oil "21t is converted by alcohol dehy­drogenase to y-hydroxybutyraldehyde, thenby aldehyde dehydrogenase to GHB. WhereasGHB is acontrolled drug in several states, GBLand 1,4-BO are not yet classified as such, andboth drugs are readily available throughchemical supply catalogs

Rachel LChin, MDJo Ellen Dyer, PharmDKarl A Sporer, MDSan Francisco General Hospital1001 Potrero Avenue, Room lE21San Francisco, CA 9411047/8/97565

1 LoVecchIO F, Curry SC, Bagnasco T Butyrolactone­Induced central nervous system depreSSIOn after IngestIOn ofRenewTnent. a "dIetary supplement" N Engl J Med1998,339 847-848

2 Dyer jE. Galbo Mj, Andrews KM I,4-Butanedwl. "pIneneedle 011," overdose mlmlCS tOXIC profIle of GHB [abstractJelm TOXlCOl 1997.35554

More on the Ottawa KneeRules

To the Editor:

Clinical decision rules hold the promise toreduce health care costs while maintainingan optimal level of patient care The emer­gency medicine community and physiciansfrom other specialties have recognized theimportance ofthe contributions of Dr IanStiell and hiS colleagues toward the develop­ment of such rules to reduce extremity radlo­graphy.1.2

Atthe same time, It is Important for othercenters to independently validate the deci­sion rules that have been developed InOttawa The report by Seaberg et al3 raisessenous concerns about the sensitivity of theOttawa knee rules If any decision rule forextremity radiography is to be widely appli­cable, it must be broadly reproducible with100% sensitiVity. Unfortunately, Seaberg'sgroup found that the Ottawa knee rule was only97% senSitive forthe detection of fractures

We also recently reported aprospectivevalidation trial ofthe Ottawa knee rules In 351patients.4 Like Seaberg et ai, we found thatthat the rule developed by Dr Stiell missedseveral fractures 4The overall sensitivity ofthe Ottawa rule in our study was only 84.6%.

The reasons that the Ottawa rules wereless sensitive In these Independenttnals areunclear One particular concern that we havehad the opportunity to diSCUSS with Dr Stiell isthatthe "Intensive" instruction thatthephysicians received In Ottawa versus the othercenters may not have been uniform. It is essen­tial to future validation studies that Dr Stielloutline in detail his methods fortraining phYSI­cians In the use ofthe Ottawa knee rules

The work ofthe group In Pittsburgh suggeststhat clinicians should not use any of the cur­rent clinical deciSIOn rules for knee radiogra­phy as arigid standard that replaces clinicaljudgment altogether. The Pittsburgh rule mustbe Independentlyvalidated and refined Atthesame time, further validation tnals oftheOttawa knee rules that ensure conformity tothe phYSician instruction methods developedby Dr Stlell are warranted

Peter BRichman, MDDepartment of Emergency MedicineMorristown Memorial HospitalMorristown, NJ47/8/97566

1 Stlell IG, Greenberg GH, McKmght RD. et al DeCISIOnmles for the use of radIOgraphy In acute ankle InJunes

RefInement and prospectlve valIdatIOn JAMA1993.269 1I27-1I32

2 StlelllG. Greenberg GH, Wells GA, et al ProspectIvevaltdatIOn of a denswn mle for the u," of radIOgraphy In

acute kna InJunel JAMA 1996,275 611-6/5

3 Seaberg DC, realy DM Lukens T, et al MultIcentercompanson of two clInIcal dwsIOn mles tor the usc ofradIOgraphy In acute. hIgh-nsk knee InJun" Ann EmngMed 1998,32 8-13

4 Richman PRo McCuskey CF, Nashed AN. et alPerformance of two clInIcal deCISIOn mles for knee radlOg­raphy J Emcrg Mcd 1997,15 459-463

4 7 6 ANNALS OF EMERGENCY MEDICINE 334 APRIL 1999